![weight loss with glp-1 agonists Top Balance Efficacy, Safety glp-1_analogs [TUSOM | Pharmwiki]](https://cdn.sanity.io/images/0vv8moc6/ajmc/4591eca94c600eae8308f44c44ec95c55d86a2fe-1200x738.jpg)
weight loss with glp-1 agonists Top Balance Efficacy, Safety glp-1_analogs [TUSOM | Pharmwiki]
Description
Espinosa, Enith
![weight loss with glp-1 agonists Top Balance Efficacy, Safety glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Vestlund and Jerlhag, 2020b), the possibility that patients with other addictions might benefit from GLP-1R therapies should be considered
Lancet 372, 12401250
![weight loss with glp-1 agonists Top Balance Efficacy, Safety glp-1_analogs [TUSOM | Pharmwiki]](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3851215011800955811)
Cell Metab 27(4):740756
![weight loss with glp-1 agonists Top Balance Efficacy, Safety glp-1_analogs [TUSOM | Pharmwiki]](https://www.mdpi.com/biomolecules/biomolecules-15-00408/article_deploy/html/images/biomolecules-15-00408-g001-550.jpg)
Sustained liraglutide administration for 3 weeks increases urinary sodium excretion independent of changes in ANP or blood pressure in overweight and obese hypertensive patients with type 2 diabetes 22
![weight loss with glp-1 agonists Top Balance Efficacy, Safety glp-1_analogs [TUSOM | Pharmwiki]](https://www.geneticlifehacks.com/wp-content/uploads/2022/11/Genetic-Variants-Related-to-GLP1-Weight-Loss-Drugs.png)
DOI : 10.3389/fphar.2025.1702448
![weight loss with glp-1 agonists Top Balance Efficacy, Safety glp-1_analogs [TUSOM | Pharmwiki]](https://b1167102.smushcdn.com/1167102/wp-content/uploads/2025/07/GLP04.jpg?lossy=2&strip=1&webp=1)
